EQIX Forensic analysis

Trading Setup & Entry Strategy

• >Action: WAIT. The current technical posture is in a corrective phase following a 20-day decline of -4.20%.
• >Entry Zones:
  • >Primary Buy Zone: $1030 - $1035 (Near the 50-day SMA support).
  • >Secondary Accumulation: $980 - $1000 (If the breakdown accelerates).
• >Stop Loss: $965 (A break below this level invalidates the bullish thesis and signals a breakdown toward the 200-day SMA at $863).
• >Take Profit: $1110 (Bollinger Upper Band) and $1150 (Psychological resistance).
• >Risk/Reward: Targeting a 1:2.5 ratio based on a current entry at $1035.

Financial Health & Recent Events

• >10-Q Insight: Q1 2026 revenue grew to $2.44B (vs $2.22B in 2025). However, Interest Expense rose significantly to $148M (vs $122M) due to recent senior note issuances.
• >Growth Concerns: While Annualized Gross Bookings were up 9%, the company faces rising costs for power and global supply chain constraints.
• [WARN]Forensic Flags: SBC remains high at $128M for the quarter, potentially masking true GAAP profitability.

Short-Term Trading Strategy (2-5 Days)

• >Timeframe: Swing Trade (2–5 Days).
• >Position Size: 3% of portfolio.
• >Scaling: Enter 30% at $1035 (50-SMA support). Add 40% only if a bullish engulfing candle appears on the daily chart. Hold 30% for momentum breakout.
• >Risk/Reward: 1:2.2.
• >Catalyst Timing: Monitor Cape Town regulatory news; if headlines shift to 'Project Approved,' look for an immediate breakout.

Investment Recommendation

HOLD. The technical setup shows a BULLISH_Uptrend on the long-term (200-SMA) but the short-term MACD is BEARISH. Wait for the $1035 support level to confirm before adding exposure. The fundamental thesis is strong, but the market is pricing in volatility from the Cape Town regulatory headwinds.

One-Liner Thesis: Equinix offers long-term infrastructure value as a backbone for AI scaling, but near-term regulatory friction and high interest costs warrant a patient entry near the 50-day SMA.